TEVA PHARMACEUTICAL-SP ADR (TEVA) Stock Analyst Earnings Estimates
NYSE:TEVA - New York Stock Exchange, Inc. - US8816242098 - ADR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 15.878B -4.69% | 14.925B -6.00% | 15.846B 6.17% | 16.756B 5.74% | 17.504B 4.46% | 17.793B 1.65% | |
| EBITDA YoY % growth | 4.748B 0.51% | 4.493B -5.37% | 4.693B 4.45% | 4.892B 4.24% | 5.348B 9.32% | 5.452B 1.94% | |
| EBIT YoY % growth | 3.418B 7.93% | 3.185B -6.82% | 3.54B 11.15% | 4.225B 19.35% | 4.625B 9.47% | 4.709B 1.82% | |
| Operating Margin | 21.53% | 21.34% | 22.34% | 25.21% | 26.42% | 26.47% | |
| EPS YoY % growth | 2.58 0.37% | 2.53 -1.94% | 2.56 1.19% | 2.48 -2.98% | 2.85 14.78% | 3.00 5.28% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.69 -31.42% | 0.52 8.80% | 0.66 8.10% | 0.76 9.61% | 0.73 7.09% |
| Revenue Q2Q % growth | 4.204B -5.68% | 4.024B 5.37% | 4.342B 4.27% | 4.557B 5.19% | 4.377B 4.12% |
| EBITDA Q2Q % growth | 1.307B -48.28% | 1.138B 24.64% | 1.363B -3.26% | 1.526B 18.57% | 1.423B 8.88% |
| EBIT Q2Q % growth | 1.193B -13.17% | 975.32M 52.16% | 1.119B 27.45% | 1.231B 5.85% | 1.267B 6.20% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.69 15.00% | 0.67 | 0.02 | 3.02% |
| Q2 2024 Q2Q % growth | 0.61 8.93% | 0.58 | 0.03 | 4.92% |
| Q1 2024 Q2Q % growth | 0.48 20.00% | 0.53 | -0.05 | -8.98% |
| Q4 2023 Q2Q % growth | 1.00 40.85% | 0.78 | 0.22 | 28.49% |
| Q3 2023 Q2Q % growth | 0.60 1.69% | 0.61 | -0.01 | -1.59% |
| Q2 2023 Q2Q % growth | 0.56 -17.65% | 0.54 | 0.02 | 3.64% |
| Q1 2023 Q2Q % growth | 0.40 -27.27% | 0.58 | -0.18 | -30.51% |
| Q4 2022 Q2Q % growth | 0.71 -7.79% | 0.78 | -0.07 | -8.41% |
| Q3 2022 Q2Q % growth | 0.59 | 0.64 | -0.05 | -7.45% |
| Q2 2022 Q2Q % growth | 0.68 15.25% | 0.61 | 0.07 | 11.11% |
| Q1 2022 Q2Q % growth | 0.55 -12.70% | 0.62 | -0.07 | -11.60% |
| Q4 2021 Q2Q % growth | 0.77 13.24% | 0.73 | 0.04 | 4.85% |
| Q3 2021 Q2Q % growth | 0.59 1.72% | 0.65 | -0.06 | -9.62% |
| Q2 2021 Q2Q % growth | 0.59 7.27% | 0.64 | -0.05 | -8.19% |
| Q1 2021 Q2Q % growth | 0.63 | 0.62 | 0.01 | 1.25% |
| Q4 2020 Q2Q % growth | 0.68 | 0.64 | 0.04 | 5.82% |
| Q3 2020 Q2Q % growth | 0.58 | 0.60 | -0.02 | -3.62% |
| Q2 2020 Q2Q % growth | 0.55 | 0.61 | -0.06 | -10.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 4.332B 12.52% | 4.221B | 111M | 2.63% |
| Q2 2024 Q2Q % growth | 4.164B 7.49% | 4.13B | 34M | 0.82% |
| Q1 2024 Q2Q % growth | 3.819B 4.15% | 3.834B | -15M | -0.39% |
| Q4 2023 Q2Q % growth | 4.457B 14.75% | 4.074B | 383M | 9.40% |
| Q3 2023 Q2Q % growth | 3.85B 7.09% | 3.794B | 56M | 1.48% |
| Q2 2023 Q2Q % growth | 3.874B 2.32% | 3.764B | 110M | 2.92% |
| Q1 2023 Q2Q % growth | 3.667B 0.16% | 3.717B | -50M | -1.35% |
| Q4 2022 Q2Q % growth | 3.884B -5.27% | 3.98B | -96M | -2.41% |
| Q3 2022 Q2Q % growth | 3.595B -7.51% | 3.948B | -353M | -8.94% |
| Q2 2022 Q2Q % growth | 3.786B -3.17% | 3.93B | -144M | -3.66% |
| Q1 2022 Q2Q % growth | 3.661B -8.06% | 3.966B | -305M | -7.69% |
| Q4 2021 Q2Q % growth | 4.1B -7.93% | 4.388B | -288M | -6.56% |
| Q3 2021 Q2Q % growth | 3.887B -2.29% | 4.077B | -190M | -4.66% |
| Q2 2021 Q2Q % growth | 3.91B 1.03% | 4.168B | -258M | -6.19% |
| Q1 2021 Q2Q % growth | 3.982B -8.61% | 4.144B | -162M | -3.91% |
| Q4 2020 Q2Q % growth | 4.453B 11.58% | 4.428B | 25M | 0.56% |
| Q3 2020 Q2Q % growth | 3.978B -2.81% | 4.129B | -151M | -3.66% |
| Q2 2020 Q2Q % growth | 3.87B -7.35% | 4.194B | -324M | -7.73% |
| Q1 2020 Q2Q % growth | 4.357B 5.01% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0.51% | 0% | 0.34% |
| Revenue | 0% | 0.29% | 1% | 1.1% |